| Table 2: SVM analysis
accurately predicts future disease severity in RA patients using ERA 19-gene
expression profiles as the training set. |
| | Training
set input | | Patient sample | SVM input | 19-gene class | Clinical class |
| | ERA1 | Severe | Severe | Severe | | ERA2 | Mild | Mild | Mild | | ERA3 | Mild | Mild | Mild | | ERA4 | Mild | Mild | Mild | | ERA6 | Severe | Severe | Severe | | ERA8 | Mild | Mild | Mild | | ERA9 | Mild | Mild | Mild | | ERA12 | Severe | Severe | Severe | | ERA13 | Severe | Severe | Severe | | ERA14 | Severe | Severe | Severe | | ERA15 | Mild | Mild | Mild | | ERA16 | Mild | Mild | Mild | | ERA20 | Mild | Mild | Mild | | ERA21 | Severe | Severe | Severe | | ERA22 | Severe | Severe | Severe | | ERA24 | Mild | Mild | Mild | | ERA25 | Severe | Severe | Severe |
| | Classified set output | | Patient sample | SVM input | SVM output | Clinical class |
| | RA1 | Unassigned | Mild | Severe | | RA2 | Unassigned | Severe | Severe | | RA3 | Unassigned | Mild | Mild | | RA4 | Unassigned | Severe | Severe | | RA5 | Unassigned | Severe | Severe | | RA6 | Unassigned | Severe | Severe | | RA7 | Unassigned | Mild | Mild | | RA8 | Unassigned | Mild | Mild | | RA9 | Unassigned | Mild | Mild |
|
|
Details of the analysis are described in the text.
|